Brief: Prometheus Biosciences Posts Q4 Revenue $1.0 Mln
09/03/2022 21:02
March 9 (Reuters) - Prometheus Biosciences Inc RXDX.O :
* PROMETHEUS BIOSCIENCES REPORTS FOURTH QUARTER AND
FULL-YEAR 2021
FINANCIAL RESULTS AND HIGHLIGHTS RECENT CORPORATE PROGRESS
* Q4 REVENUE $1.0 MILLION
Source text for Eikon: ID:nGNX4jNz81
Further company coverage: RXDX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results